liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
Univ Minnesota, MN 55455 USA.
Univ Minnesota, MN 55455 USA.
Univ Minnesota, MN 55455 USA.
Univ Virginia, VA 22908 USA.
Visa övriga samt affilieringar
2019 (Engelska)Ingår i: International Journal of Molecular Sciences, ISSN 1422-0067, E-ISSN 1422-0067, Vol. 20, nr 1, artikel-id 229Artikel, forskningsöversikt (Refereegranskat) Published
Abstract [en]

Ovarian cancer is the leading cause of death from gynecologic malignancy in the Western world. This is due, in part, to the fact that despite standard treatment of surgery and platinum/paclitaxel most patients recur with ultimately chemoresistant disease. Ovarian cancer is a unique form of solid tumor that develops, metastasizes and recurs in the same space, the abdominal cavity, which becomes a unique microenvironment characterized by ascites, hypoxia and low glucose levels. It is under these conditions that cancer cells adapt and switch to mitochondrial respiration, which becomes crucial to their survival, and therefore an ideal metabolic target for chemoresistant ovarian cancer. Importantly, independent of microenvironmental factors, mitochondria spatial redistribution has been associated to both tumor metastasis and chemoresistance in ovarian cancer while specific sets of genetic mutations have been shown to cause aberrant dependence on mitochondrial pathways in the most aggressive ovarian cancer subtypes. In this review we summarize on targeting mitochondria for treatment of chemoresistant ovarian cancer and current state of understanding of the role of mitochondria respiration in ovarian cancer. We feel this is an important and timely topic given that ovarian cancer remains the deadliest of the gynecological diseases, and that the mitochondrial pathway has recently emerged as critical in sustaining solid tumor progression.

Ort, förlag, år, upplaga, sidor
MDPI , 2019. Vol. 20, nr 1, artikel-id 229
Nyckelord [en]
ascites; OXPHOS; mitochondrial inhibitor; chemoresistant ovarian cancer; SWI; SNF complex
Nationell ämneskategori
Medicinsk genetik
Identifikatorer
URN: urn:nbn:se:liu:diva-155620DOI: 10.3390/ijms20010229ISI: 000459747700229PubMedID: 30626133OAI: oai:DiVA.org:liu-155620DiVA, id: diva2:1297726
Anmärkning

Funding Agencies|Department of Defense Ovarian Cancer Research Program [OC160377]; Minnesota Ovarian Cancer Alliance; Randy Shaver Cancer Research Funds

Tillgänglig från: 2019-03-20 Skapad: 2019-03-20 Senast uppdaterad: 2019-08-29

Open Access i DiVA

fulltext(1438 kB)91 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1438 kBChecksumma SHA-512
2c5a4309ea0f0afac25ded9350451d2a7ce7e16c4df036c2a8f3c89b30add21facb54afcbb1fc647d68bf07344f9caf6b0142fd9f149a1ac22e398f1069f9a9b
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Sök vidare i DiVA

Av författaren/redaktören
Linder, Stig
Av organisationen
Avdelningen för läkemedelsforskningMedicinska fakulteten
I samma tidskrift
International Journal of Molecular Sciences
Medicinsk genetik

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 91 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 112 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf